Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Cholangiocarcinoma 2Triple Negative Breast Neoplasms 1Sarcoma, Kaposi 1Prostatic Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Leukemia, Myeloid, Acute 1Breast Neoplasms 1

Interventions

Cisplatin 2avelumab 1Paclitaxel 1Ifosfamide 1Everolimus 1Disulfiram 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Neoplasms, Germ Cell and Embryonal × Everolimus × Clear all
NCT01466231 2016-01-12

Everolimus in Refractory Testicular Germ Cell Cancer

National Cancer Institute, Slovakia

Phase 2 Completed
15 enrolled

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡